<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04310033</url>
  </required_header>
  <id_info>
    <org_study_id>38RC19.420</org_study_id>
    <secondary_id>2019-A03307-40</secondary_id>
    <nct_id>NCT04310033</nct_id>
  </id_info>
  <brief_title>Impact of ICU on the Quality of Life in Cancer Patients</brief_title>
  <acronym>QdV-ONCOREA</acronym>
  <official_title>Impact of ICU on the Quality of Life and Oncological Care of Patients With Solid Tumors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an observational, prospective, monocentric, case-control study. Investigators aim to
      compare the quality of life and oncological treatment strategy in cancer patients admitted or
      not in ICU.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Inclusion of cancer patients (cases) at discharge of surgical, cardiovascular and thoracic
      and medical ICU of the Grenoble Alpes University Hospital.

      Cases will be matched with cancer patients identified in oncologist's consultation.

      Inclusion of controls from oncologist consultations (2 controls for 1 case) For cases and
      controls, medical data will be collected at inclusion, 3 and 6 months.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 24, 2020</start_date>
  <completion_date type="Anticipated">August 2021</completion_date>
  <primary_completion_date type="Anticipated">February 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>quality of life questionary 36-item short form survey instrument (36-SF)</measure>
    <time_frame>3 months</time_frame>
    <description>score of 0 (poor quality of life) to 100 (very good quality of life)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>intensity of antitumoral treatment compared to standard treatment</measure>
    <time_frame>3 months</time_frame>
    <description>standard treatment vs adaptated treatment vs palliative care standard treatment was defined by the treatment recommended in the ESMO guidelines for each cancer (lung, colorectal, and head and neck cancer)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>quality of life questionary 36-item short form survey instrument (36-SF)</measure>
    <time_frame>6 months</time_frame>
    <description>score of 0 (poor quality of life) to 100 (very good quality of life)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>intensity of antitumoral treatment compared to standard treatment</measure>
    <time_frame>6 months</time_frame>
    <description>standard treatment vs adaptated treatment vs palliative care standard treatment was defined by the treatment recommended in the ESMO guidelines for each cancer (lung, colorectal, and head and neck cancer)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ECOG - Performance status</measure>
    <time_frame>3 months and 6 months</time_frame>
    <description>From 0 (fully active) to 5 (dead)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Activities of Daily Living</measure>
    <time_frame>6 months</time_frame>
    <description>From 0 (dependent ) to 6 (autonomous)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Anxiety and Depression Scale</measure>
    <time_frame>3 months and 6 months</time_frame>
    <description>Anxiety scale from 0 (no anxiety) to 21 (anxiety) Depression Scale from 0 (no depression) to 21 (depression)</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Solid Tumor, Adult</condition>
  <arm_group>
    <arm_group_label>Cases</arm_group_label>
    <description>&gt; 18 years old
Non-opposition of the patient or relatives
Lung, head and neck or colorectal cancer
Non scheduled ICU admission
At least 24 hours of ICU stay
Alive at ICU discharge
Able to answer by phone to quality of life questionary</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <description>Cancer patients not admitted in ICU, matched with the cases according to
the type of primary cancer
the presence or absence of oncogenic addiction
the setting of anticancer treatment (curative/palliative)
the line of anticancer treatment (none/L1/L2-L3/&gt;L3).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaires</intervention_name>
    <description>Quality of life questionary: 36-Item Short Form Survey Instrument (36-SF) at 3 and 6 months from inclusion By phone</description>
    <arm_group_label>Cases</arm_group_label>
    <arm_group_label>Controls</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Lung, head and neck or colorectal cancer admitted in ICU (cases) or not (controls)
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt; 18 ans

          -  Non-opposition of the patient or relatives

          -  Lung, head and neck or colorectal cancer

          -  Non scheduled ICU admission

          -  At least 24 hours of ICU stay

          -  Alive at ICU discharge

          -  Able to answer by phone to quality of life questionary

        Exclusion Criteria:

          -  Unable to answer by phone to quality of life questionary

          -  Patient participating in another clinical study that could interfere with the results
             of the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Anne-Claire Toffart, MD, PhD</last_name>
    <phone>+33 476 765 453</phone>
    <email>AToffart@chu-grenoble.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christine Tchikladze</last_name>
    <phone>+33 476 767 032</phone>
    <email>CTchikladze@chu-grenoble.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Chu Grenoble Alpes</name>
      <address>
        <city>Grenoble Cedex 9</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>TOFFART Anne-Claire, PH</last_name>
      <phone>+33 476 765 453</phone>
      <email>AToffart@chu-grenoble.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>February 20, 2020</study_first_submitted>
  <study_first_submitted_qc>March 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 17, 2020</study_first_posted>
  <last_update_submitted>March 12, 2020</last_update_submitted>
  <last_update_submitted_qc>March 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Quality of life</keyword>
  <keyword>Oncological care</keyword>
  <keyword>intensive care unit</keyword>
  <keyword>solid tumor</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

